EVO - Evotec launches data analysis platform PanHunter
- Evotec ( NASDAQ: EVO ) on Tuesday said that it launched the first commercial version of its PanOmics data analysis platform PanHunter at Bio-IT World in Berlin.
- Evotec is now making PanHunter available to collaborators and partners as a software-as-a-service (SaaS) product. The analytics platform has been used successfully internally and in drug discovery partnerships over many years, the German company added.
- Evotec noted that the PanOmics data have information on the condition of respective patients, the molecular biological context, and causes of diseases.
For further details see:
Evotec launches data analysis platform PanHunter